IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
FEDERAL LOBBYING RECORDS

LOBBYING FILINGS AND MARKET CONTEXT

Indexed federal lobbying filings mapped to clients, registrants, and public-company tickers. Transaction dates are compared with filing periods to identify date-proximity review flags. Proximity does not establish coordination, influence, or wrongdoing.

Filings tracked
20,641
thru 2026-07-15
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,260
paying companies
Tickers targeted
1,219
public companies

Clients by reported amount

Mapped tickers by reported amount

#TickerFilingsTotal $
1META
Meta Platforms Inc.
134$50.3M
2PFE
Pfizer Inc.
89$48.7M
3GM
General Motors Company
103$48.4M
4V
Visa Inc.
47$37.7M
5AMZN
Amazon.com Inc.
82$35.4M
6LMT
Lockheed Martin Corporation
92$29.5M
7FDX
FedEx Corporation
83$28.4M
8LLY
Eli Lilly and Company
88$28.4M
9AMGN
Amgen Inc.
100$28.0M
10MRK
Merck & Co. Inc.
92$27.5M
11AAPL
Apple Inc.
66$27.0M
12GOOGL
Alphabet Inc. Class A
128$26.8M
13MO172$26.4M
14SO
Southern Company
110$26.2M
15UNH
UnitedHealth Group Inc.
68$24.0M
16VZ
Verizon Communications Inc.
119$23.8M
17TMUS170$22.9M
18CHTR142$22.8M
19GD
General Dynamics Corporation
131$22.6M
20T
AT&T Inc.
137$21.7M
21ORCL
Oracle Corporation
135$20.8M
22CMCSA
Comcast Corporation
142$20.5M
23OXY
Occidental Petroleum Corporation
38$20.1M
24CI
The Cigna Group
64$19.9M
25MSFT
Microsoft Corporation
126$19.3M

🆕 Filtered Filings · NTRA

clear filters
DateTickerClientRegistrantAmountIssue
2026-07-10NTRANATERA INCNATERA INC$150KAdvocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
2026-07-05NTRANATERA INC.LMH STRATEGIC SOLUTIONS$20KCoverage and reimbursement for innovative lab-developed tests. H.R.5269: RESULTS Act.
2026-04-20NTRANATERAAKIN GUMP STRAUSS HAUER & FELD$0
2026-04-17NTRANATERA INC.ERVIN GRAVES STRATEGY GROUP, LLC$30KInsurance coverage for laboratory testing.
2026-04-15NTRANATERA INC.THE CONSILIO GROUP$54KExpanded Genetic Screening Act. Expanded Genetic Screening Act.
2026-04-14NTRANATERA INCNATERA INC$150KAdvocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
2026-04-09NTRANATERA INC.THE CONSILIO GROUP$39KNon-invasive prenatal screening test (NIPT) Non-invasive prenatal screening test (NIPT)
2026-03-31NTRANATERA INC.ERVIN GRAVES STRATEGY GROUP, LLC$0Insurance coverage for laboratory testing. Insurance coverage for laboratory testing. Insurance coverage for laboratory testing. Insurance coverage for laboratory testing.
2026-01-20NTRANATERAAKIN GUMP STRAUSS HAUER & FELD$10KIssues related to Centers for Medicare & Medicaid Services preauthorization.
2026-01-14NTRANATERA INC.THE CONSILIO GROUP$54KExpanded Genetic Screening Act. Expanded Genetic Screening Act.
2026-01-12NTRANATERA INCNATERA INC$150KAdvocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
2025-10-20NTRANATERA INC.THE CONSILIO GROUP$54KExpanded Genetic Screening Act. Expanded Genetic Screening Act.
2025-10-20NTRANATERAAKIN GUMP STRAUSS HAUER & FELD$0
2025-10-15NTRANATERA INCNATERA INC$150KAdvocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
2025-07-22NTRANATERA INC.THE CONSILIO GROUP$54KExpanded Genetic Screening Act. Expanded Genetic Screening Act.
2025-07-21NTRANATERAAKIN GUMP STRAUSS HAUER & FELD$0
2025-07-18NTRANATERA INCNATERA INC$140KAdvocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
2025-04-21NTRANATERAAKIN GUMP STRAUSS HAUER & FELD$0
2025-04-15NTRANATERA INCNATERA INC$140KAdvocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
2025-04-15NTRANATERA INC.THE CONSILIO GROUP$54KExpanded Genetic Screening Act. Expanded Genetic Screening Act.
2025-02-07NTRANATERA INCNATERA INC$0Any federal legislation or regulations in regard to health care testing and diagnostics.
2025-01-21NTRANATERAAKIN GUMP STRAUSS HAUER & FELD$0